Loading people...
Nelli Morgulchik is a solo angel investor based in Tel Aviv, Israel, focusing on early-stage opportunities within the biotechnology, deeptech, and healthcare sectors. Prior to her current independent investing activities, she served as an Investor at Hummingbird Ventures, where she evaluated emerging life sciences enterprises and deeptech platforms. Her professional background includes executing corporate strategy and business development initiatives across various global pharmaceutical corporations and early-stage startups. In her current capacity, Morgulchik writes individual investment checks ranging from $1,000 to $10,000, specifically targeting ventures at the foundational idea or initial patent stages. Additionally, she actively mentors aspiring venture capitalists and life sciences entrepreneurs, seeking to back exceptional founders who demonstrate non-linear career trajectories. Morgulchik currently focuses on leveraging her institutional venture capital background and pharmaceutical industry expertise to identify and capitalize on nascent biotech innovations.
Nelli Morgulchik is Investor at Hummingbird Ventures, based in London, United Kingdom.